MobiHealth News October 3, 2022
Emily Olsen

A review published in JAMA Network Open evaluated 41 RCTs of machine learning interventions. None of the studies fully followed CONSORT-AI standards, a set of guidelines developed for clinical trials evaluating medical interventions that include AI.

A review of studies published in JAMA Network Open found few randomized clinical trials for medical machine learning algorithms, and researchers noted quality issues in many published trials they analyzed.

The review included 41 RCTs of machine learning interventions. It found 39% were published just last year, and more than half were conducted at single sites. Fifteen trials took place in the U.S., while 13 were conducted in China. Six studies were conducted in multiple countries.

Only 11 trials collected race and ethnicity...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Clinical Trials, Survey / Study, Technology, Trends
Parexel strikes deal with Palantir for clinical trial AI
Risklick debuts new AI software that writes clinical trial protocols
“Intentional effort” needed from sponsors to achieve diversity in oncology clinical trials
It’s Time to Give Patients a Seat at the Table
LabConnect Agrees to Acquire A4P Consulting

Share This Article